News

  1. Home
  2. News

Check out our new OPEN ACCESS publication: ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’

Shubaash Anthiya, Süleyman Can Öztürk, Hamdullah Yanik, Ece Tavukcuoglu, Adem Şahin, Dhrubajyoti Datta, Klaus Charisse, David Moreira Álvarez, María Isabel Loza, Alfonso Calvo, Einar Sulheim, Simon Loevenich, Geir Klinkenberg, Ruth Schmid, Muthiah Manoharan, Güneş Esendağlı, Maria Jose Alonso, 'Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors', Journal of Controlled Release.

MJ Alonso’s Lab Mini-Congress 2022

The Alonso’s Lab mini-congress is an annual event aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work.

MJ Alonso’s Lab wishes you a happy New Year!

Happy New Year to everyone! We wish you a fabulous 2023, full of great experiences and achievements in science.

María José Alonso receives the “Doctora de Alcalá” Award from the University of Alcalá de Henares

The Spanish Forum of Innovative Companies – Foro Español de Empresas Innovadoras (FEI) has distinguished María José Alonso in its annual awards in the category of ‘Researcher / Innovator 2022’

María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin

This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.

The Spanish Forum of Innovative Companies recognizes María José Alonso as ‘Researcher / Innovator 2022’

The Spanish Forum of Innovative Companies – Foro Español de Empresas Innovadoras (FEI) has distinguished María José Alonso in its annual awards in the category of ‘Researcher / Innovator 2022’

María José Alonso receives the ASEICA-Woman Award

Professor Alonso has been recognized for her work in promoting and mentoring cancer researchers’ careers.

Meet Robert Langer, a pioneer in the development of modern RNA vaccines

Prof. María José Alonso interviews Prof. Robert Langer, one of the fathers of nanomedicine. Prof. Langer’s interdisciplinary work has had an extraordinary impact in the design and development of novel nanocarriers for the delivery of small molecule drugs and nucleic acids.

María José Alonso, ‘Honoris Causa’ by the University of Nottingham

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has just been awarded...

EU Project B-SMART releases interview clip: “The Journey of siRNA’

Over the past 5.5 years, we have partnered a EU-funded research project B-SMART intended to explore and establish new gateways to reach the brain in the hopes of better addressing brain-related illnesses, such as Alzheimer’s disease.